Serum Talin-1 and Cripto-1 in Colorectal Cancer

Starting soon · Not applicable

Conditions studied: Colo-rectal Cancer

In brief

The goals of this study are * To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls. * To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA

Key facts

Study ID

NCT07414082

Run by

Assiut University

People needed

70

Starts

2026-03-30

Expected to finish

2029-12-31

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age >18 years Old.
• Patients of both sexes who met the clinical diagnostic criteria of colorectal cancer (change in bowel habit, absolute or recurrent constipation, rectal bleeding, significant weight loss or intestinal obstruction)
• Patients diagnosed with colorectal cancer by imaging and histopathology

You may not qualify if…

• Age <18 years old.
• Patients with past history of chemotherapy or surgical excision of tumor
• Patients with familial adenomatous polyposis
• Patients with hereditary non-polyposis colorectal cancer
• Patients with inflammatory bowel disease
• patients with other types of tumors

Where it is running

• Assuit University Hospital — Asyut, Asyut Governorate, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.